NMDA receptors may link psychosis and sleep deficits

Sofya Kulikova, a researcher at HSE University in Perm, is part of an international research team that has discovered potential mechanisms that explain the sleep spindle deficit in electroencephalograms (EEG) of people with schizophrenia. The article was published in the Schizophrenia Research on June 5. https://www.sciencedirect.com/science/article/abs/pii/S092099642030236X?via%3Dihub&fbclid=IwAR2VFGlKtqeYMsdtFidYS5yNpbarRGRA8Wts6TkIOCiWyDfkBot7z_yJs7w Individuals with schizophrenia are often characterized by a deficit…

Details

New tool employs air travel data to predict global spread of COVID-19

As the COVID-19 pandemic enters a new phase, punctuated by emerging hot spots and continuing global spread, a new analytical tool developed by RAND Corporation researchers allows policymakers to predict regional risks of importing cases of COVID-19. The tool, which melds information on infection rates with global air traffic data, has already produced a number…

Details

Are kidney transplant patients at higher risk? The European experience

Experience throughout the world, including in Europe, shows that advanced age is the most important risk factor for death in COVID-19: people aged over 70 years are over 10 times more likely to die compared to those aged below 50. Other factors increasing the risk of death include male sex and comorbidities, including obesity, hypertension,…

Details

COVID-19 mortality alarmingly high in dialysis patients

Spain is one of the European countries besides the UK and Italy that was particularly hard hit by the coronavirus pandemic in March. Early on, it was not possible to predict the extent of the outbreak. The first case in Spain was a German tourist who brought the virus to La Gomera in the Canary…

Details

Narayanan studying application of brilacidin for treatment of coronavirus infections

Narayanan Studying Application Of Brilacidin For Treatment Of Coronavirus Infections Aarthi Narayanan, Assistant Professor, National Center for Biodefense and Infectious Diseases, received $35,000 from Innovation Pharmaceuticals, Inc., for a project in which she is examining the use of Brilacidin for the treatment of coronavirus infections. Brilacidin is an investigational new drug. It is a polymer-based…

Details

Acute kidney injury and end stage kidney disease in severe COVID-19

Germany was not hit as hard by the SARS-CoV-2 pandemic as many other European countries. The reason for this is that the wave of infection reached Germany later, that the authorities were warned by the situation in Italy and Spain and at an early stage ordered a lockdown and conducted extensive testing. Up to June…

Details

New killing mechanism discovered in ‘game-changing’ antibiotic

Scientists at the University of Liverpool and University of Utrecht have taken another step forward on their quest to develop a viable drug based on teixobactin — a new class of potent natural antibiotic capable of killing superbugs. Research published in Nature Communications provides fundamental new insights into how teixobactins kill bacteria, including the discovery…

Details

Fitful nightly sleep linked to chronic inflammation, hardened arteries

Disrupted nightly sleep and clogged arteries tend to sneak up on us as we age. And while both disorders may seem unrelated, a new study from the University of California, Berkeley, helps explain why they are, in fact, pathologically intertwined. UC Berkeley sleep scientists have begun to reveal what it is about fragmented nightly sleep…

Details